“Many scientists believe that this year could be a breakthrough in finding cures for cancer in DNA and investors could get familiar with terms like… Read More »Which Biotech Stocks Are Best Positioned To Profit From The Gene Editing Boom?
Three biotech companies developing therapies for the treatment of cancer and other diseases – including infectious diseases like COVID-19 – began trading on Friday.
“Make no mistake: These stocks are risky. Nonetheless, each of these companies has a few factors in its favor aside from being popular with retail… Read More »3 High-Risk, High-Reward Biotech Stocks With “Millionaire-Maker Potential”
Which biotech stocks will be the next to reward risk-tolerant investors with massive returns?
The four penny stocks highlighted in today’s article are all biopharmaceutical/biotech companies, they can all be bought for under $4, and they all have important… Read More »Which Of These Biotech Penny Stocks Are Worth The Under-$4 Price Of Admission?
“September has historically been the worst-performing month for stocks – and today’s article identifies the stocks that have shown themselves to be the worst stocks… Read More »The Worst Month’s Worst Stocks
Biotech Start-ups poised to take off in the next 12 months.
Profitable Biotech Stocks with a high probability of putting profits in your pocket right now.
Biotech IPOs have helped drug developers raise over $5 billion so far this year.
Top five mid-cap companies that have been experiencing insider buying amid the coronavirus crisis.